Our results reveal a role for RPL34-AS1 in ESCC tumorigenesis and may provide a strategy for using RPL34-AS1 as a potential biomarker and an effect target for patients with ESCC. The gene discussed is RPL34; the disease is esophageal squamous cell carcinoma.